Ramelteon for Complex Insomnia in Veterans With PTSD (NCT03265951) | Clinical Trial Compass
WithdrawnPhase 4
Ramelteon for Complex Insomnia in Veterans With PTSD
Stopped: Lack of response
United States0Started 2018-01-01
Plain-language summary
Obstructive sleep apnea is commonly reported in Veterans with post-traumatic stress disorder, which can potentiate symptoms of anxiety and depression, daytime symptoms and worsen nightmares. Continuous positive airway pressure is the most effective therapy but adherence to treatment is suboptimal. The overarching theme of the proposal is to compare usual care to Ramelteon, in a randomized, clinical trial, investigating the effectiveness of physiological versus pharmacological intervention on sleep quality of life, insomnia severity and CPAP adherence.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥18 years and ≤70 years old
* Diagnosis of PTSD as determined by the intake conducted through the PTSD Clinic or the Mental Health Clinic
* Documented obstructive sleep apnea by polysomnography (AHI≥5 or more/hour)
* CPAP non adherence defined as less than 70% of nights with \>4h CPAP use despite addressing modifiable barriers for CPAP adherence
* Psychotherapeutic treatment stable for at least 4 weeks prior to randomization
* Capable of giving informed consent
Exclusion Criteria:
* Medical:
* Acute or unstable chronic medical illness
* History of narcolepsy and/or cataplexy Use of any of these medications: Fluvoxamine, fluconazole (Diflucan), itraconazole (Sporanox), and ketoconazole (Nizoral); cimetidine (Tagamet); clarithromycin (Biaxin); fluoroquinolones including ciprofloxacin, levofloxacin (Levaquin), moxifloxacin (Avelox), norfloxacin (Noroxin), ofloxacin (Floxin), others; HIV protease inhibitors including indinavir (Crixivan), nelfinavir (Viracept), and ritonavir (Norvir, in Kaletra); nefazodone; rifampin
* Treatment for seizure disorders
* Pregnant or lactating
* History of clinically significant hepatic impairment
* History of hypersensitivity, intolerance, or contraindication to ramelteon
* Unwilling to try or use CPAP
Psychiatric/Behavioral:
* Diagnosis of current schizophrenia or schizoaffective disorder
* Diagnosis of a substance dependence/abuse disorder in the past year
* Severe psychiatric instability or severe si…